The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

In a study of Eli Lilly’s Zepbound, weight loss increased (PDF) from 20.9% after 36 weeks to 25.8% after 88 weeks. The top-line data shared by Novo Friday lack important details, including ...

Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Zepbound is a prescription injectable medication that’s used for weight loss ... Zepbound is given once per week. It is stored in the refrigerator and does not need to be at room temperature ...

Zepbound is an ... breathing interruptions per hour. Furthermore, up to 50% of participants no longer exhibited symptoms of OSA. The medication also promotes weight loss, with patients losing ...

Sales of blockbuster weight-loss drugs have surged in 2024 ... at a cheaper price. A four-week supply of the 2.5 mg Zepbound single-dose vials costs $399, while a four-week supply of the 5 mg ...